Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking the first projected drop since Ozempic...
Weight-Loss
Eli Lilly (NYSE: LLY) just announced plans to invest $3.5 billion in a new manufacturing plant in Pennsylvania’s Lehigh Valley area. This facility will focus...
Novo Nordisk A/S (NYSE: NVO, CSE: NOVO-B) starts selling the first oral GLP-1 drug for weight loss in the U.S. today. This Wegovy pill gives...
In a move that has escalated competition in the growing obesity treatment market, Danish pharmaceutical company Novo Nordisk A/S (NASDAQ: NVO) has made an unsolicited...
